About the Hespen Rally
Join us in raising money to help find a cure for cholangiocarcinoma as we race from Birmingham to Detroit. The Hespen Rally will be a fun-filled day of great cars, an amazing drive to Belle Isle, and lunch with friends and family of Patrick Hespen.
Sunday, August 6, 2017
Time: 11:00 a.m.
Meet up in Birmingham, Michigan
The event will begin at 11:00 a.m. in the parking lot of Pasteiner’s Auto Zone Hobbies. If you have not pre-registered, you will be able to register on site. Get a chance to look at the other vehicles, get a cup of coffee, and meet with fellow Rally goers. We will review the Rally information and hope to get on our way by 11:30 a.m.
End on Belle Isle in Detroit
The convoy will head south towards Belle Isle in Detroit. By 1:30 p.m., all of the vehicles will (hopefully) have made it to the Dossin Great Lakes Museum. Enjoy lunch, an impromptu car show, and the waterfront of the beautiful Detroit River.
Join the Journey.
We invite Patrick's friends, family, and colleagues, as well as members of the media and car enthusiasts to join us at the Hespen Rally.
ABOUT PATRICK HESPEN
Cars formed the bookends to Patrick Hespen’s all-too-brief life. He was born in 1978 into a car family – his dad sold Volkswagens in Cleveland – and Patrick grew up tinkering with engines. He was in the military and served in the Middle East before getting his dream job working in the auto industry, first with Audi and then as a communications manager with Ford and then Fiat Chrysler. It was especially in these last two roles where Patrick’s effervescent personality, encyclopedic knowledge of cars and his incredible work ethic – he’d help anybody at anytime – attracted hundreds of new friends. Patrick, who maintained his lifelong passion for Volkswagens, passed away in December from a rare form of bile duct cancer. At his funeral, automakers set aside their rivalries and honored Patrick with 2,100 horsepower salute of revving engines. We honor Patrick and keep his friendship alive with the first Hespen Rally to combat Bile Duct Cancer.